Clinical Trial Update: Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia? [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update exploring whether sulphonylurea therapy preserves cortical function during hypoglycaemia in patients with Type 1 Diabetes Mellit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Sulphonylurea (class) (sulphonylurea class)

Snippet

Sponsor: King's College Hospital NHS Trust | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: UNKNOWN